Literature DB >> 11121747

The molecular basis of T helper 1 and T helper 2 cell differentiation.

A O'Garra1, N Arai.   

Abstract

Cytokines such as interleukin 12 (IL-12) and IL-4 are dominant factors in driving the development of T helper 1 (Th1) and Th2 cells, respectively, through specific signalling pathways. In addition, it has been demonstrated more recently that T helper-cell-specific transcription factors exist that determine the commitment of Th1 and Th2 cells for the production of distinct profiles of cytokines. In addition to the expression of distinct cytokine genes and transcription factors, the molecular basis for commitment to a Th1 or Th2 phenotype can probably be explained by multiple mechanisms, including differential cytokine signalling, exclusive cytokine receptor expression, differential expression of transcription factors and/or differential chromatin remodelling of Th1- and Th2-specific genes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11121747     DOI: 10.1016/s0962-8924(00)01856-0

Source DB:  PubMed          Journal:  Trends Cell Biol        ISSN: 0962-8924            Impact factor:   20.808


  111 in total

1.  rVista for comparative sequence-based discovery of functional transcription factor binding sites.

Authors:  Gabriela G Loots; Ivan Ovcharenko; Lior Pachter; Inna Dubchak; Edward M Rubin
Journal:  Genome Res       Date:  2002-05       Impact factor: 9.043

2.  Morphine, but not ketamine, decreases the ratio of Th1/Th2 in CD4-positive cells through T-bet and GATA3.

Authors:  Mei Gao; Jie Sun; Wenjie Jin; Yanning Qian
Journal:  Inflammation       Date:  2012-06       Impact factor: 4.092

3.  Inhibition of interleukin-12 expression by alpha-thrombin in human peripheral blood mononuclear cells: a potential mechanism for modulating Th1/Th2 responses.

Authors:  A Naldini; L Aarden; A Pucci; C Bernini; F Carraro
Journal:  Br J Pharmacol       Date:  2003-09-29       Impact factor: 8.739

4.  GATA-3 deficiency abrogates the development and maintenance of T helper type 2 cells.

Authors:  Sung-Yun Pai; Morgan L Truitt; I-Cheng Ho
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-09       Impact factor: 11.205

Review 5.  Peroxynitrite, a potent macrophage-derived oxidizing cytotoxin to combat invading pathogens.

Authors:  Carolina Prolo; María Noel Alvarez; Rafael Radi
Journal:  Biofactors       Date:  2013-11-26       Impact factor: 6.113

6.  IL-4 inhibits VLA-4 expression on Tc1 cells resulting in poor tumor infiltration and reduced therapy benefit.

Authors:  Kotaro Sasaki; Angela D Pardee; Hideho Okada; Walter J Storkus
Journal:  Eur J Immunol       Date:  2008-10       Impact factor: 5.532

Review 7.  Anti-cytokine vaccines and the immunotherapy of autoimmune diseases.

Authors:  David C Wraith
Journal:  Eur J Immunol       Date:  2006-11       Impact factor: 5.532

8.  Relative quantification of mRNA levels in Jurkat T cells with RT-real time-PCR (RT-rt-PCR): new possibilities for the screening of anti-inflammatory and cytotoxic compounds.

Authors:  Jürg Gertsch; Martin Güttinger; Otto Sticher; Jörg Heilmann
Journal:  Pharm Res       Date:  2002-08       Impact factor: 4.200

9.  Synergistic effects of soluble PD-1 and IL-21 on antitumor immunity against H22 murine hepatocellular carcinoma.

Authors:  Xiu-Cheng Pan; Li Li; Juan-Juan Mao; Wei Yao; Jun-Nian Zheng; Mei Liu; Juan-Juan Fu
Journal:  Oncol Lett       Date:  2012-10-12       Impact factor: 2.967

10.  Genetic association of nonsynonymous variants of the IL23R with familial and sporadic inflammatory bowel disease in women.

Authors:  Zhenwu Lin; Lisa Poritz; Andre Franke; Tong-Yi Li; Andreas Ruether; Kathryn A Byrnes; Yunhua Wang; Anthony W Gebhard; Colin MacNeill; Neal J Thomas; Stefan Schreiber; Walter A Koltun
Journal:  Dig Dis Sci       Date:  2009-03-18       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.